“We will Appraise how the commercialization of the substance matches in with our organization product at Adastra in an effort to situation ourselves to guidance the demand from customers for a safe supply of copyright,” stated Main govt officer Michael Forbes in a news release. The company informed VICE News it would not be commenting even more